期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

120例维持性血液透析患者维生素D水平及相关因素分析 被引量：1

下载PDF
导出
摘要 终末期。肾病已成为威胁全球人类健康的重大疾病之一．如何改善此类患者的生活质量．延长其生命，系多年来医学界普遍关注的一个问题。其中矿物质和骨代谢紊乱（mineral and bone disorder，MBD）系该病较为常见的临床表现，它不仅可导致骨营养不良，而且可促进心血管并发症的发生，故严重影响患者的生活质量及寿命。近年来国内外多项研究表明，维生素D代谢紊乱是MBD的重要发病机制之一，
作者 陈红艳 黄柏勇
机构地区 解放军
出处 《实用医药杂志》 2015年第10期912-913,共2页 Practical Journal of Medicine & Pharmacy
关键词 血液透析 维生素D 矿物质和骨代谢紊乱 影响因素
分类号 R459.5 [医药卫生—治疗学]
  • 相关文献

参考文献6

  • 1Wolf M,Thadhani R.Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease[J]. Semin Dial, 2005,18 (4) : 302-306.
  • 2王宓,邵茁,王梅.慢性肾脏病229例25羟基维生素D浓度及影响因素分析[J].中国实用内科杂志,2012,32(2):138-141. 被引量：11
  • 3王嘉琳,袁伟杰.活性维生素D与营养性维生素D在慢性肾脏病治疗中的临床地位[J].肾脏病与透析肾移植杂志,2011,20(2):173-175. 被引量：6
  • 4Del Valle E,Negri AL,Aguirre C,et al. Prevalence of 25(0H) vitamin D insufficiency and deficiency in chronic kidney dis- ease stage 5 patienta on hemodialysis[J]. Hemodial Int,2007, 11 (3) :315-321.
  • 5Elder GJ. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease[J]. J Bone Miner Res, 2006,21 ( 11 ) : 1778-1784.
  • 6Norman AW. Sunlight,season,skin pigmentation,vitamin D,and 25-Hydroxyvitamin D:integral components of the vitamin D endocrine system[J]. Am J Clin Nutr, 1998,67(6) : 1108-1110.

二级参考文献34

  • 1Taskapan H,Wei M,Oreopoulos DG.25(0H) vitamin D3 in patients with chronic kidney disease and those on dialysis:rediscovering its importance.Int Urol Nephrol,2006,38(2):323-329.
  • 2Kalantar-Zadeh K,Shah A,et al.Kidney bone disease and mortality in CKD:The role of vitamin D,alkaline phosphatase and minerals.Kidney Int,2010,117(Suppl):S10-S21.
  • 3Wolf M,Shah A,Gutierrez O,et al.Vitamin D levels and early mortality among incident hemodialysis patients.Kidney Int,2007,72(8):1004-1013.
  • 4Teng M,Wolf M,Ofsthun MN,et al.Activated injectable vitamin D and hemodialysis survival:A historical cohort study.J Am Soc Nephrol,2005,16(4):1115-1125.
  • 5Kalantar-Zadeh K,Kuwae N,Regidor DL,et al.Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.Kidney Int,2006,70(4):771-780.
  • 6Shinaberger CS,Kopple JD,Kovesdy CP,et al.Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients.Clin J Am Soc Nephrol,2008,3(6):1769-1776.
  • 7Young EW,Albert JM,Satayathum S,et al.Predictorsand consequences of altered mineral metabolism:the Dialysis Outcomes and Practice Patterns Study.Kidney lnt,2005,67(3):1179-1187.
  • 8Brown AJ,Slatopolsky E.Drug insight:vitamin D analogs in the treatment of secondary hyperpantthyroidism in patients with chronic kidney disease.Nat Clin Pract Endocrinol Metab,2007,3(2):134-144.
  • 9Dukkipati R,Kovesdy CP,Colman S,et al.Association of relatively low Serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.J Ren Nutr,2010,20(4):243-254.
  • 10Al-Aly Z,Qazi RA,González EA,et al.Changes in serum 25-hydroxyvitamin D and plasma intact FM levels following treatment with ergocalciferol in patients with CKD.Am J Kidney Dis,2007,50(1):59-68.

共引文献14

同被引文献9

引证文献1

实用医药杂志
2015年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部